EMA Sets Up COVID-19 Task Force

News
Article

The task force will assist in the developing, authorizing, and monitoring of treatments of COVID-19.

To assist member states of the European Union in developing, authorizing, and monitoring treatments of COVID-19, the European Medicines Agency (EMA) has set up the COVID-19 EMA Pandemic Task Force (COVID-ETF). The task force is accountable to EMA’s Committee for Medicinal Products for Human Use (CHMP) and will include CHMP rapporteurs and co-rapporteurs and any additional experts that may be needed, the agency announced in a April 9, 2020 press release.

The COVID-ETF will review available scientific data on possible COVID-19 treatments as well as request data from developers. The task force will also offer scientific support to facilitate clinical trials of COVID-19 treatments and provide feedback on development plans. It will advise the Scientific Advice Working Party or CHMP on formal scientific advice and product-related assessment and contribute to Pharmacovigilance Risk Assessment Committee activities. It will also ensure cooperation with stakeholders and European and international organizations.

Source: EMA

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content